Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ORAGENICS INCFinancial_Report.xls
EX-31.2 - SECTION 302 CFO CERTIFICATION - ORAGENICS INCd333982dex312.htm
EX-10.6 - DEBT EXCHANGE AGREEMENT - ORAGENICS INCd333982dex106.htm
10-Q - FORM 10-Q - ORAGENICS INCd333982d10q.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - ORAGENICS INCd333982dex311.htm
EX-10.5 - SENIOR SECURED PROMISSORY NOTE - ORAGENICS INCd333982dex105.htm
EX-32.2 - SECTION 906 CFO CERTIFICATION - ORAGENICS INCd333982dex322.htm
EX-10.7 - LOAN AGREEMENT - ORAGENICS INCd333982dex107.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. Section 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Oragenics, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John N. Bonfiglio Ph.D., President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written certification has been provided to the company and will be retained by the company and furnished to the Securities and Exchange Commission or its staff upon request.

Dated this 15th day of May, 2012.

 

/s/ John N. Bonfiglio Ph.D.

John N. Bonfiglio Ph.D.

President and Chief Executive Officer